Medtronic EBIT 2010-2024 | MDT
Medtronic annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
- Medtronic EBIT for the quarter ending October 31, 2024 was $1.594B, a 18.96% increase year-over-year.
- Medtronic EBIT for the twelve months ending October 31, 2024 was $5.410B, a 2.82% decline year-over-year.
- Medtronic 2024 annual EBIT was $5.145B, a 6.2% decline from 2023.
- Medtronic 2023 annual EBIT was $5.485B, a 4.66% decline from 2022.
- Medtronic 2022 annual EBIT was $5.753B, a 28.3% increase from 2021.
| Medtronic Annual EBIT (Millions of US $) |
|
|---|---|
| 2024 | $5,145 |
| 2023 | $5,485 |
| 2022 | $5,753 |
| 2021 | $4,484 |
| 2020 | $4,791 |
| 2019 | $6,268 |
| 2018 | $6,640 |
| 2017 | $5,383 |
| 2016 | $5,361 |
| 2015 | $3,766 |
| 2014 | $3,813 |
| 2013 | $4,755 |
| 2012 | $4,748 |
| 2011 | $4,297 |
| 2010 | $4,714 |
| 2009 | $3,833 |
| Medtronic Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2024-10-31 | $1,594 |
| 2024-07-31 | $1,280 |
| 2024-04-30 | $1,053 |
| 2024-01-31 | $1,483 |
| 2023-10-31 | $1,340 |
| 2023-07-31 | $1,269 |
| 2023-04-30 | $1,567 |
| 2023-01-31 | $1,391 |
| 2022-10-31 | $1,403 |
| 2022-07-31 | $1,124 |
| 2022-04-30 | $1,672 |
| 2022-01-31 | $1,659 |
| 2021-10-31 | $1,563 |
| 2021-07-31 | $859 |
| 2021-04-30 | $1,604 |
| 2021-01-31 | $1,277 |
| 2020-10-31 | $930 |
| 2020-07-31 | $673 |
| 2020-04-30 | $316 |
| 2020-01-31 | $1,639 |
| 2019-10-31 | $1,351 |
| 2019-07-31 | $1,485 |
| 2019-04-30 | $1,946 |
| 2019-01-31 | $1,542 |
| 2018-10-31 | $1,544 |
| 2018-07-31 | $1,236 |
| 2018-04-30 | $1,928 |
| 2018-01-31 | $1,436 |
| 2017-10-31 | $1,894 |
| 2017-07-31 | $1,382 |
| 2017-04-30 | $1,684 |
| 2017-01-31 | $1,147 |
| 2016-10-31 | $1,385 |
| 2016-07-31 | $1,167 |
| 2016-04-30 | $1,575 |
| 2016-01-31 | $1,355 |
| 2015-10-31 | $1,300 |
| 2015-07-31 | $1,131 |
| 2015-04-30 | $159 |
| 2015-01-31 | $1,275 |
| 2014-10-31 | $1,193 |
| 2014-07-31 | $1,139 |
| 2014-04-30 | $305 |
| 2014-01-31 | $1,025 |
| 2013-10-31 | $1,206 |
| 2013-07-31 | $1,277 |
| 2013-04-30 | $1,191 |
| 2013-01-31 | $1,218 |
| 2012-10-31 | $1,186 |
| 2012-07-31 | $1,160 |
| 2012-04-30 | $1,215 |
| 2012-01-31 | $1,153 |
| 2011-10-31 | $1,221 |
| 2011-07-31 | $1,159 |
| 2011-04-30 | $982 |
| 2011-01-31 | $1,147 |
| 2010-10-31 | $1,089 |
| 2010-07-31 | $1,079 |
| 2010-04-30 | $1,056 |
| 2010-01-31 | $1,267 |
| 2009-10-31 | $1,224 |
| 2009-07-31 | $1,167 |
| 2009-04-30 | $660 |
| 2009-01-31 | $980 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $116.457B | $32.364B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $222.392B | 27.46 |
| Boston Scientific (BSX) | United States | $154.781B | 41.84 |
| Stryker (SYK) | United States | $150.988B | 32.49 |
| EssilorLuxottica (ESLOY) | France | $128.761B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.724B | 0.00 |
| Haleon (HLN) | United Kingdom | $43.049B | 27.97 |
| Agilent Technologies (A) | United States | $42.120B | 27.91 |
| GE HealthCare Technologies (GEHC) | United States | $40.456B | 20.98 |
| ResMed (RMD) | United States | $34.834B | 26.83 |
| Terumo (TRUMY) | Japan | $27.701B | 39.39 |
| Koninklijke Philips (PHG) | Netherlands | $25.801B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $20.443B | 12.84 |
| Insulet (PODD) | United States | $20.179B | 80.36 |
| Baxter (BAX) | United States | $15.731B | 10.24 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.039B | 0.00 |
| Sunny Optical Technology (SNPTF) | China | $9.976B | 0.00 |
| BellRing Brands (BRBR) | United States | $9.951B | 37.15 |
| Bio-Rad Laboratories (BIO) | United States | $9.670B | 32.87 |
| Demant (WILYY) | Denmark | $7.946B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $6.320B | 14.69 |
| Prestige Consumer Healthcare (PBH) | United States | $4.316B | 20.65 |
| ICU Medical (ICUI) | United States | $3.878B | 36.92 |
| Envista Holdings (NVST) | United States | $3.750B | 29.85 |
| Perrigo (PRGO) | Ireland | $3.407B | 10.03 |
| Haemonetics (HAE) | United States | $3.164B | 14.89 |
| GN Store Nord (GNNDY) | Denmark | $3.123B | 21.05 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $2.989B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.832B | 18.23 |
| Neogen (NEOG) | United States | $2.315B | 26.67 |
| LeMaitre Vascular (LMAT) | United States | $2.245B | 54.55 |
| AtriCure (ATRC) | United States | $1.997B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $1.513B | 26.48 |
| AdaptHealth (AHCO) | United States | $1.300B | 9.29 |
| InMode (INMD) | Israel | $1.269B | 10.61 |
| Maravai LifeSciences Holdings (MRVI) | United States | $1.250B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.215B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.069B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.996B | 15.27 |
| Evolus (EOLS) | United States | $0.849B | 0.00 |
| CeriBell (CBLL) | United States | $0.810B | 0.00 |
| Owens & Minor (OMI) | United States | $0.667B | 5.21 |
| Capricor Therapeutics (CAPR) | United States | $0.652B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.627B | 27.14 |
| Valneva SE (VALN) | France | $0.563B | 0.00 |
| Omeros (OMER) | United States | $0.526B | 0.00 |
| SNDL (SNDL) | Canada | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.487B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.474B | 0.00 |
| Verano Holdings (VRNOF) | United States | $0.424B | 0.00 |
| ZimVie (ZIMV) | United States | $0.383B | 32.26 |
| Canopy Growth (CGC) | Canada | $0.363B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.343B | 62.50 |
| Cerus (CERS) | United States | $0.323B | 0.00 |
| Quanterix (QTRX) | United States | $0.320B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.317B | 30.11 |
| Sanara MedTech (SMTI) | United States | $0.309B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.292B | 19.55 |
| Biote (BTMD) | United States | $0.261B | 5.73 |
| Zynex (ZYXI) | United States | $0.252B | 52.80 |
| High Tide (HITI) | Canada | $0.238B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.232B | 3.26 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.226B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.209B | 0.00 |
| TerrAscend (TSNDF) | Canada | $0.209B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.203B | 15.16 |
| Brainsway (BWAY) | Israel | $0.200B | 106.40 |
| MacroGenics (MGNX) | United States | $0.174B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.164B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.142B | 17.83 |
| Jin Medical (ZJYL) | China | $0.130B | 0.00 |
| Quipt Home Medical (QIPT) | United States | $0.127B | 0.00 |
| Fonar (FONR) | United States | $0.101B | 11.44 |
| Exagen (XGN) | United States | $0.093B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.089B | 0.00 |
| Veru (VERU) | United States | $0.085B | 0.00 |
| InterCure (INCR) | Israel | $0.080B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.073B | 0.00 |
| INLIF (INLF) | $0.067B | 0.00 | |
| Rockwell Medical (RMTI) | United States | $0.064B | 33.00 |
| Cytosorbents (CTSO) | United States | $0.057B | 0.00 |
| Ayr Wellness (AYRWF) | United States | $0.055B | 0.00 |
| Apyx Medical (APYX) | United States | $0.052B | 0.00 |
| MariMed (MRMD) | United States | $0.051B | 0.00 |
| United-Guardian (UG) | United States | $0.051B | 14.60 |
| Modular Medical (MODD) | United States | $0.048B | 0.00 |
| ImmuCell (ICCC) | United States | $0.048B | 0.00 |
| Safety Shot (SHOT) | United States | $0.035B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.017B | 0.00 |
| Nephros (NEPH) | United States | $0.016B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.014B | 0.00 |
| Flora Growth (FLGC) | United States | $0.013B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.013B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.012B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.009B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.008B | 0.00 |
| Agape ATP (ATPC) | $0.005B | 0.00 | |
| IM Cannabis (IMCC) | Canada | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.002B | 0.00 |
| Sharps Technology (STSS) | United States | $0.002B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.001B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |